Two Blokes

Here's Why This $50 Healthcare Stock Could Be the Next $200 Winner

  • click to rate
    Posted by Two Blokes Jul 20 - Filed in Stock - 1 view
    A decade ago, shares of Exelixis (EXEL -0.89%), a biotech company specializing in oncology, were trading for under $10 per share. Today, the drugmaker's shares are changing hands for about $45 apiece.